25
total announcements
CHOKSILA.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 04 Nov 2026
Market Cap
₹141 Cr
P/E (TTM)
64.9
EPS (TTM)
₹3.11
52W Low
₹81.85
52W High
₹227.90
Dividend Yield
0.00%
Beta
0.29
Price / Book
5.5
Debt / Equity
133.6
Revenue (TTM)
₹47 Cr
Gross Margin
40.92%
Operating Margin
10.89%
Choksi Laboratories Ltd
Choksi Laboratories Ltd has submitted its unaudited financial results for the quarter ended 30th June 2026, which were approved by the Audit Committee and Board of Directors. The results are accompanied by a Limited Review Report from the independent auditor, PRATEEK JAIN & Co.
Choksi Laboratories Ltd
Choksi Laboratories Ltd announced its Board Meeting outcome on August 13, 2026. The Board considered and approved the Unaudited Financial Results for the Quarter ended on June 30, 2026, along with the Limited review report. The Board also decided the date for closure of Register of Members and share transfer Books for the 33rd Annual General Meeting. Other operational, financial, and administrative matters were discussed and necessary resolutions passed.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has scheduled a Board Meeting on 13th August 2026 to consider and approve unaudited financial results for the quarter ended 30th June 2026, appointment of internal auditor, and other matters.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has changed its Registrar and Share Transfer Agent (RTA) from MUFG Intime India Private Limited to Ankit Consultancy Private Limited, effective August 3, 2026. The company has published a notice in the Free Press Journal and Choutha Sansar newspapers on August 4, 2026.
Choksi Laboratories Ltd
Choksi Laboratories Ltd has announced a change in its Registrar and Transfer Agent (RTA) from MUFG Intime India Private Limited to Ankit Consultancy Private Limited, effective August 3, 2026, as per Regulation 30 of SEBI (LODR) 2015.